---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-129965"
form_type: "8-K"
ticker: "VIVS"
cik: "0001497253"
company_name: "VivoSim Labs, INC."
filed_at: "2024-11-22T23:59:59+00:00"
generated_at: "2026-05-29T19:41:45.520225+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Organovo shareholders approve reverse stock split (1:5-1:20) and 1.78M share equity plan increase

## Summary
- Reverse stock split authorized at ratio 1-to-5 to 1-to-20, board discretion until Nov 20, 2025; 88.64% voted for.
- 2022 Equity Incentive Plan amended to add 1,775,000 shares; 89.41% approval.
- Class I directors Alison Tjosvold Milhous and Vaidehi Joshi elected with ~92.4% and ~93.9% of votes cast, respectively.
- Rosenberg Rich Baker Berman ratified as auditor for FY ending March 2025 (89.25% approval).
- Advisory vote on named executive officer compensation passed with 92.30% of votes cast.

## SEC filing metadata
- accession: 0000950170-24-129965
- form_type: 8-K
- ticker: VIVS
- cik: 0001497253
- company_name: VivoSim Labs, INC.
- filed_at: 2024-11-22T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1497253/000095017024129965/0000950170-24-129965-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1497253/000095017024129965/onvo-20241120.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-129965
- JSON: https://secwatch.observer/filing/0000950170-24-129965.json
- Plain text: https://secwatch.observer/filing/0000950170-24-129965.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.